Healthcare Sector Stocks
The Healthcare sector has a total of 1057 stocks, with a combined market cap of $9.11 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 49.19.
Market Cap
9.11T
Revenue
4.66T
Profits
185.26B
PE Ratio
49.19
Profit Margin
3.98%
Dividend Yield
0.38%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.05T | -1.11% | 924,393 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 619.18B | -0.02% | 1,660,605 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 432.98B | 0.47% | 1,277,434 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 370.11B | 0.88% | 1,572,557 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 316.96B | -0.03% | 3,191,036 | 66.57B |
| 6 | NVS | Novartis AG | 292.81B | 1.13% | 631,089 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 247.26B | -0.30% | 1,449,510 | 61.37B |
| 8 | AMGN | Amgen Inc. | 219.77B | 0.41% | 461,563 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 216.37B | 0.89% | 572,323 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 200.17B | 1.99% | 5,541,100 | 50.34B |
| 11 | ABT | Abbott Laboratories | 186.02B | -0.42% | 2,082,198 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 165.87B | 2.22% | 2,692,531 | 30.46B |
| 13 | PFE | Pfizer Inc. | 150.67B | 0.90% | 18,148,430 | 63.70B |
| 14 | DHR | Danaher Corporation | 142.44B | 1.32% | 909,710 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 133.27B | 0.95% | 1,180,191 | 11.03B |
| 16 | BMY | Bristol-Myers Squibb Company | 131.43B | 0.30% | 2,405,701 | 49.19B |
| 17 | SYK | Stryker Corporation | 129.71B | 0.22% | 581,869 | 25.84B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 124.49B | 1.47% | 249,583 | 12.59B |
| 19 | CVS | CVS Health Corporation | 122.06B | -0.81% | 4,290,807 | 412.65B |
| 20 | MDT | Medtronic plc | 110.29B | 0.28% | 1,530,299 | 36.36B |
| 21 | GSK | GSK plc | 104.39B | 1.51% | 1,325,735 | 44.05B |
| 22 | MCK | McKesson Corporation | 102.65B | 1.04% | 777,879 | 410.98B |
| 23 | SNY | Sanofi | 102.59B | 1.33% | 1,457,175 | 55.89B |
| 24 | HCA | HCA Healthcare, Inc. | 89.06B | 0.61% | 326,930 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 85.17B | 0.34% | 225,801 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.10B | 1.30% | 164,688 | 15.53B |
| 27 | CI | The Cigna Group | 74.12B | 1.90% | 1,223,734 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 71.75B | 0.43% | 4,492,813 | 21.00B |
| 29 | COR | Cencora, Inc. | 61.37B | -1.05% | 427,118 | 332.77B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 55.84B | 2.44% | 2,125,352 | 28.42B |
| 31 | CAH | Cardinal Health, Inc. | 55.74B | 0.14% | 484,811 | 250.74B |
| 32 | ARGX | argenx SE | 54.32B | 0.78% | 58,912 | 5.32B |
| 33 | EW | Edwards Lifesciences Corporation | 51.61B | 0.25% | 655,701 | 6.51B |
| 34 | BDX | Becton, Dickinson and Company | 48.41B | -0.77% | 616,037 | 22.48B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 46.41B | -0.15% | 245,116 | 4.55B |
| 36 | MDLN | Medline Inc. | 46.41B | 2.29% | 3,008,968 | 29.94B |
| 37 | HUM | Humana Inc. | 45.86B | 3.98% | 488,823 | 145.68B |
| 38 | NTRA | Natera, Inc. | 45.21B | 18.64% | 1,769,788 | 2.71B |
| 39 | HLN | Haleon plc | 43.92B | -0.05% | 3,095,521 | 14.80B |
| 40 | RVMD | Revolution Medicines, Inc. | 42.08B | 0.06% | 381,198 | - |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 40.97B | 1.01% | 1,956,652 | 17.32B |
| 42 | A | Agilent Technologies, Inc. | 40.81B | 2.24% | 365,582 | 7.23B |
| 43 | WAT | Waters Corporation | 39.67B | 1.08% | 191,121 | 4.64B |
| 44 | ONC | BeOne Medicines AG | 39.35B | 4.94% | 339,942 | 6.13B |
| 45 | IQV | IQVIA Holdings Inc. | 38.74B | 1.26% | 225,280 | 16.98B |
| 46 | VEEV | Veeva Systems Inc. | 37.02B | 4.63% | 1,336,230 | 3.32B |
| 47 | ALC | Alcon Inc. | 33.86B | 2.29% | 996,525 | 10.63B |
| 48 | RPRX | Royalty Pharma plc | 32.87B | -0.16% | 854,783 | 2.54B |
| 49 | CNC | Centene Corporation | 32.57B | 2.71% | 1,307,373 | 180.30B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 31.99B | 0.74% | 883,093 | 21.27B |
| 51 | DXCM | DexCom, Inc. | 31.78B | 1.45% | 1,618,118 | 4.97B |
| 52 | ZTS | Zoetis Inc. | 30.79B | -4.95% | 6,005,121 | 9.53B |
| 53 | BIIB | Biogen Inc. | 30.44B | -0.14% | 236,534 | 10.03B |
| 54 | RMD | ResMed Inc. | 30.38B | -5.66% | 1,912,380 | 5.65B |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | 28.88B | -0.15% | 700,359 | 4.80B |
| 56 | ILMN | Illumina, Inc. | 28.68B | -1.96% | 718,284 | 4.49B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.55B | 0.26% | 22,753 | 4.13B |
| 58 | INSM | Insmed Incorporated | 27.63B | -4.51% | 1,813,746 | 1.14B |
| 59 | DGX | Quest Diagnostics Incorporated | 26.33B | 0.03% | 139,388 | 11.56B |
| 60 | ROIV | Roivant Sciences Ltd. | 25.94B | 2.68% | 2,555,672 | 7.53M |
| 61 | PHG | Koninklijke Philips N.V. | 25.87B | 1.18% | 377,716 | 20.18B |
| 62 | LH | Labcorp Holdings Inc. | 25.76B | 0.33% | 120,715 | 14.35B |
| 63 | WST | West Pharmaceutical Services, Inc. | 24.93B | 1.62% | 101,717 | 3.33B |
| 64 | INCY | Incyte Corporation | 24.27B | 1.14% | 466,031 | 5.82B |
| 65 | BNTX | BioNTech SE | 23.34B | 1.89% | 874,290 | 3.03B |
| 66 | MRNA | Moderna, Inc. | 23.02B | 7.07% | 2,549,671 | 2.23B |
| 67 | STE | STERIS plc | 22.96B | 1.65% | 219,821 | 6.04B |
| 68 | UTHR | United Therapeutics Corporation | 22.71B | -0.63% | 659,225 | 3.15B |
| 69 | GH | Guardant Health, Inc. | 22.24B | 5.19% | 1,068,241 | 1.18B |
| 70 | THC | Tenet Healthcare Corporation | 21.04B | 1.83% | 220,201 | 21.81B |
| 71 | VTRS | Viatris Inc. | 19.31B | 1.78% | 4,321,196 | 14.74B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.37B | -0.88% | 802,385 | 8.51B |
| 73 | GMAB | Genmab A/S | 17.27B | 4.26% | 2,208,076 | 4.13B |
| 74 | ASND | Ascendis Pharma A/S | 16.79B | 1.95% | 123,770 | 998.25M |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 16.71B | 0.29% | 326,942 | 4.60B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 16.69B | 2.76% | 327,729 | 3.37B |
| 77 | MEDP | Medpace Holdings, Inc. | 16.26B | -0.41% | 45,850 | 2.78B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 16.11B | -0.50% | 430,221 | 579.96M |
| 79 | COO | The Cooper Companies, Inc. | 14.46B | 1.10% | 542,254 | 4.23B |
| 80 | BAX | Baxter International Inc. | 14.11B | 1.07% | 2,558,526 | 11.47B |
| 81 | SOLV | Solventum Corporation | 14.06B | -0.41% | 285,546 | 8.31B |
| 82 | EXEL | Exelixis, Inc. | 13.20B | 2.03% | 1,025,125 | 2.44B |
| 83 | BTSG | BrightSpring Health Services, Inc. | 13.16B | 3.75% | 727,144 | 14.37B |
| 84 | RVTY | Revvity, Inc. | 12.80B | 0.47% | 234,144 | 2.91B |
| 85 | PEN | Penumbra, Inc. | 12.80B | 0.04% | 105,202 | 1.50B |
| 86 | FMS | Fresenius Medical Care AG | 12.79B | 0.58% | 570,188 | 22.19B |
| 87 | ICLR | ICON Public Limited Company | 12.55B | 0.93% | 114,064 | 8.29B |
| 88 | CRL | Charles River Laboratories International, Inc. | 12.48B | -1.50% | 166,050 | 4.00B |
| 89 | SNN | Smith & Nephew plc | 12.43B | 1.15% | 910,467 | 6.30B |
| 90 | EHC | Encompass Health Corporation | 12.39B | 0.45% | 240,087 | 6.21B |
| 91 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.26B | 1.12% | 324,876 | 669.50M |
| 92 | BMRN | BioMarin Pharmaceutical Inc. | 12.16B | 2.34% | 2,427,975 | 3.41B |
| 93 | ALGN | Align Technology, Inc. | 12.09B | 0.63% | 330,725 | 4.14B |
| 94 | HALO | Halozyme Therapeutics, Inc. | 11.93B | 17.24% | 4,167,612 | 1.66B |
| 95 | CORT | Corcept Therapeutics Incorporated | 11.87B | 1.71% | 198,466 | 830.81M |
| 96 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.85B | 0.49% | 98,083 | 1.28B |
| 97 | ELAN | Elanco Animal Health Incorporated | 11.60B | -4.09% | 10,504,276 | 5.02B |
| 98 | DVA | DaVita Inc. | 11.56B | 0.33% | 457,505 | 14.01B |
| 99 | ABVX | ABIVAX Société Anonyme | 11.37B | 1.28% | 484,849 | 5.67M |
| 100 | TECH | Bio-Techne Corporation | 11.25B | 0.44% | 1,905,352 | 1.21B |
| 101 | GMED | Globus Medical, Inc. | 11.17B | 1.48% | 1,598,197 | 3.14B |
| 102 | SMMT | Summit Therapeutics Inc. | 11.03B | 2.14% | 810,903 | - |
| 103 | AXSM | Axsome Therapeutics, Inc. | 10.81B | -0.05% | 260,624 | 708.24M |
| 104 | ENSG | The Ensign Group, Inc. | 10.52B | 0.24% | 56,992 | 5.49B |
| 105 | GKOS | Glaukos Corporation | 10.45B | 3.64% | 279,271 | 612.84M |
| 106 | UHS | Universal Health Services, Inc. | 10.42B | 1.37% | 96,055 | 18.11B |
| 107 | CYTK | Cytokinetics, Incorporated | 10.39B | -5.99% | 1,958,247 | 67.67M |
| 108 | RDY | Dr. Reddy's Laboratories Limited | 10.26B | 0.74% | 1,084,533 | 3.50B |
| 109 | MOH | Molina Healthcare, Inc. | 10.12B | 1.27% | 92,647 | 42.47B |
| 110 | APGE | Apogee Therapeutics, Inc. | 10.10B | 0.07% | 881,107 | - |
| 111 | PRAX | Praxis Precision Medicines, Inc. | 9.85B | -4.52% | 186,402 | 7.46M |
| 112 | HSIC | Henry Schein, Inc. | 9.83B | -0.02% | 140,405 | 13.60B |
| 113 | PODD | Insulet Corporation | 9.72B | 0.62% | 601,592 | 3.05B |
| 114 | KRYS | Krystal Biotech, Inc. | 9.58B | 0.26% | 53,540 | 440.48M |
| 115 | PTGX | Protagonist Therapeutics, Inc. | 9.31B | -1.01% | 86,669 | 281.99M |
| 116 | BIO | Bio-Rad Laboratories, Inc. | 9.26B | 1.10% | 55,343 | 2.59B |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 9.20B | 1.65% | 528,176 | 874.09M |
| 118 | SYRE | Spyre Therapeutics, Inc. | 9.16B | 0.45% | 193,059 | - |
| 119 | AVTR | Avantor, Inc. | 9.10B | 2.12% | 2,364,847 | 6.56B |
| 120 | RGEN | Repligen Corporation | 9.10B | 1.12% | 309,318 | 785.10M |
| 121 | TEM | Tempus AI, Inc. | 9.08B | 9.17% | 2,572,324 | 1.43B |
| 122 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.90B | -0.02% | 743,808 | 42.16M |
| 123 | KYMR | Kymera Therapeutics, Inc. | 8.81B | -0.39% | 207,598 | 105.00M |
| 124 | QGEN | Qiagen N.V. | 8.79B | 1.87% | 1,262,739 | 2.10B |
| 125 | HQY | HealthEquity, Inc. | 8.73B | 0.96% | 199,267 | 1.34B |
| 126 | ATR | AptarGroup, Inc. | 8.67B | 0.45% | 280,015 | 3.93B |
| 127 | OSCR | Oscar Health, Inc. | 8.39B | 2.56% | 5,397,288 | 15.32B |
| 128 | PCVX | Vaxcyte, Inc. | 8.31B | -2.22% | 541,319 | - |
| 129 | ALKS | Alkermes plc | 8.23B | 1.43% | 306,266 | 1.67B |
| 130 | BRKR | Bruker Corporation | 8.09B | 3.53% | 671,978 | 3.50B |
| 131 | IMVT | Immunovant, Inc. | 8.05B | -1.84% | 253,074 | - |
| 132 | IBRX | ImmunityBio, Inc. | 7.94B | 2.39% | 4,817,245 | 165.79M |
| 133 | LQDA | Liquidia Corporation | 7.88B | -0.96% | 189,762 | 288.07M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.83B | 1.46% | 339,200 | 239.92M |
| 135 | PACS | PACS Group, Inc. | 7.54B | 1.97% | 380,671 | 5.55B |
| 136 | COGT | Cogent Biosciences, Inc. | 7.22B | 1.03% | 652,516 | - |
| 137 | HIMS | Hims & Hers Health, Inc. | 7.21B | 4.99% | 4,109,104 | 2.37B |
| 138 | CHE | Chemed Corporation | 7.15B | -0.08% | 65,890 | 2.60B |
| 139 | TWST | Twist Bioscience Corporation | 7.11B | 3.89% | 449,823 | 431.80M |
| 140 | TGTX | TG Therapeutics, Inc. | 6.97B | -0.69% | 495,629 | 799.54M |
| 141 | GRFS | Grifols, S.A. | 6.95B | 2.43% | 198,169 | 8.48B |
| 142 | HNGE | Hinge Health, Inc. | 6.85B | 10.51% | 1,123,769 | 720.06M |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.60B | - | 516,421 | 1.56B |
| 144 | CGON | CG Oncology, Inc. | 6.56B | -0.58% | 227,091 | 6.23M |
| 145 | BLTE | Belite Bio, Inc | 6.44B | 1.92% | 61,127 | - |
| 146 | MIRM | Mirum Pharmaceuticals, Inc. | 6.43B | 5.25% | 319,165 | 618.07M |
| 147 | ERAS | Erasca, Inc. | 6.28B | -0.99% | 627,819 | - |
| 148 | TXG | 10x Genomics, Inc. | 6.19B | 6.84% | 1,693,753 | 616.91M |
| 149 | SRRK | Scholar Rock Holding Corporation | 6.18B | -2.09% | 392,964 | - |
| 150 | CAI | Caris Life Sciences, Inc. | 6.13B | 8.40% | 3,373,199 | 989.61M |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 6.07B | -2.73% | 312,737 | 7.50M |
| 152 | DNTH | Dianthus Therapeutics, Inc. | 6.04B | -1.68% | 141,164 | 1.90M |
| 153 | TFX | Teleflex Incorporated | 6.04B | -1.84% | 172,325 | 2.25B |
| 154 | DFTX | Definium Therapeutics, Inc. | 6.01B | -1.89% | 1,508,067 | - |
| 155 | PTCT | PTC Therapeutics, Inc. | 5.99B | 1.24% | 355,086 | 1.01B |
| 156 | KNSA | Kiniksa Pharmaceuticals International, plc | 5.93B | -0.74% | 70,280 | 840.85M |
| 157 | ORKA | Oruka Therapeutics, Inc. | 5.89B | -0.79% | 90,586 | - |
| 158 | BLCO | Bausch + Lomb Corporation | 5.88B | 0.67% | 90,177 | 5.32B |
| 159 | TVTX | Travere Therapeutics, Inc. | 5.81B | -1.33% | 356,032 | 591.33M |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 5.78B | -2.76% | 111,686 | 290.54M |
| 161 | AMRX | Amneal Pharmaceuticals, Inc. | 5.75B | -0.22% | 242,438 | 3.12B |
| 162 | RDNT | RadNet, Inc. | 5.55B | 3.53% | 330,924 | 2.14B |
| 163 | STVN | Stevanato Group S.p.A. | 5.55B | 0.15% | 120,221 | 1.40B |
| 164 | MMED | MiniMed Group, Inc. | 5.40B | 4.40% | 352,823 | 3.10B |
| 165 | SHC | Sotera Health Company | 5.38B | -0.21% | 1,043,483 | 1.22B |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.31B | 1.38% | 320,244 | 1.58B |
| 167 | CRSP | CRISPR Therapeutics AG | 5.15B | 3.14% | 590,445 | 13.39M |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.98B | 1.56% | 541,405 | 1.14B |
| 169 | DOCS | Doximity, Inc. | 4.95B | 33.40% | 47,479,095 | 655.57M |
| 170 | DYN | Dyne Therapeutics, Inc. | 4.73B | -2.16% | 479,589 | - |
| 171 | WAY | Waystar Holding Corp. | 4.70B | 4.84% | 2,630,930 | 1.21B |
| 172 | MANE | Veradermics, Incorporated | 4.61B | 1.56% | 182,495 | - |
| 173 | EWTX | Edgewise Therapeutics, Inc. | 4.59B | -4.01% | 290,300 | - |
| 174 | INDV | Indivior Pharmaceuticals, Inc. | 4.55B | -0.28% | 452,554 | 1.33B |
| 175 | ICUI | ICU Medical, Inc. | 4.55B | 9.38% | 405,441 | 2.16B |
| 176 | NVST | Envista Holdings Corporation | 4.54B | 3.23% | 1,361,946 | 2.86B |
| 177 | CON | Concentra Group Holdings Parent, Inc. | 4.47B | 14.34% | 764,401 | 2.29B |
| 178 | PBLS | Parabilis Medicines, Inc. | 4.46B | -1.63% | 71,617 | - |
| 179 | CELC | Celcuity Inc. | 4.42B | -2.90% | 199,493 | - |
| 180 | BLLN | BillionToOne, Inc. | 4.36B | 0.86% | 732,851 | 397.41M |
| 181 | ITGR | Integer Holdings Corporation | 4.26B | -0.57% | 327,856 | 1.84B |
| 182 | IRTC | iRhythm Holdings, Inc. | 4.25B | 1.05% | 1,059,779 | 825.34M |
| 183 | ELVN | Enliven Therapeutics, Inc. | 4.21B | -0.03% | 203,778 | - |
| 184 | LFST | LifeStance Health Group, Inc. | 4.18B | 2.72% | 1,463,173 | 1.58B |
| 185 | RLAY | Relay Therapeutics, Inc. | 4.16B | -3.39% | 874,605 | 10.35M |
| 186 | LIVN | LivaNova PLC | 4.13B | -1.02% | 228,996 | 1.47B |
| 187 | LEGN | Legend Biotech Corporation | 3.95B | 5.86% | 1,413,323 | 1.14B |
| 188 | VKTX | Viking Therapeutics, Inc. | 3.93B | 1.23% | 515,252 | - |
| 189 | ADPT | Adaptive Biotechnologies Corporation | 3.92B | 3.98% | 1,045,305 | 308.08M |
| 190 | HAE | Haemonetics Corporation | 3.91B | 1.04% | 162,732 | 1.35B |
| 191 | TNGX | Tango Therapeutics, Inc. | 3.90B | -6.93% | 888,927 | 56.99M |
| 192 | DNLI | Denali Therapeutics Inc. | 3.88B | -1.17% | 788,121 | 3.60M |
| 193 | TLX | Telix Pharmaceuticals Limited | 3.87B | 8.27% | 140,623 | 803.79M |
| 194 | VCYT | Veracyte, Inc. | 3.76B | 1.37% | 244,803 | 561.90M |
| 195 | GPCR | Structure Therapeutics Inc. | 3.65B | -2.32% | 157,231 | - |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.60B | -0.25% | 356,956 | 117.00M |
| 197 | OPCH | Option Care Health, Inc. | 3.57B | 0.76% | 989,824 | 5.69B |
| 198 | OGN | Organon & Co. | 3.56B | 0.07% | 526,295 | 6.13B |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.52B | 0.52% | 161,910 | 234.13M |
| 200 | ALMS | Alumis Inc. | 3.49B | -1.47% | 252,224 | 8.40M |
| 201 | NHC | National HealthCare Corporation | 3.44B | 0.40% | 71,556 | 1.56B |
| 202 | BKD | Brookdale Senior Living Inc. | 3.42B | -0.38% | 1,030,629 | 3.00B |
| 203 | WRBY | Warby Parker Inc. | 3.29B | -0.96% | 2,128,553 | 911.61M |
| 204 | CLDX | Celldex Therapeutics, Inc. | 3.26B | -0.11% | 292,591 | 158.00K |
| 205 | NAMS | NewAmsterdam Pharma Company N.V. | 3.23B | -0.09% | 210,217 | 7.12M |
| 206 | ARQT | Arcutis Biotherapeutics, Inc. | 3.23B | -2.76% | 874,691 | 463.98M |
| 207 | MBX | MBX Biosciences, Inc. | 3.14B | -1.86% | 158,017 | - |
| 208 | QURE | uniQure N.V. | 3.13B | -0.46% | 912,169 | 18.67M |
| 209 | GRAL | GRAIL, Inc. | 2.97B | 4.91% | 567,829 | 165.26M |
| 210 | ALHC | Alignment Healthcare, Inc. | 2.97B | 7.03% | 2,138,107 | 4.58B |
| 211 | GRDN | Guardian Pharmacy Services, Inc. | 2.96B | 18.37% | 366,595 | 1.46B |
| 212 | IRON | Disc Medicine, Inc. | 2.95B | -0.85% | 121,824 | - |
| 213 | PLSE | Pulse Biosciences, Inc. | 2.89B | 9.36% | 433,617 | 1.19M |
| 214 | ACHC | Acadia Healthcare Company, Inc. | 2.88B | 0.62% | 334,185 | 3.37B |
| 215 | TARS | Tarsus Pharmaceuticals, Inc. | 2.86B | -0.23% | 340,278 | 606.33M |
| 216 | KOD | Kodiak Sciences Inc. | 2.84B | 0.22% | 186,178 | - |
| 217 | PRVA | Privia Health Group, Inc. | 2.83B | 0.55% | 619,141 | 2.36B |
| 218 | IMNM | Immunome, Inc. | 2.82B | -3.54% | 257,630 | 4.02M |
| 219 | TMDX | TransMedics Group, Inc. | 2.79B | 0.39% | 227,359 | 668.47M |
| 220 | RGC | Regencell Bioscience Holdings Limited | 2.76B | 2.11% | 73,817 | - |
| 221 | SUPN | Supernus Pharmaceuticals, Inc. | 2.73B | 0.51% | 244,375 | 830.44M |
| 222 | BEAM | Beam Therapeutics Inc. | 2.73B | 0.18% | 529,134 | 156.04M |
| 223 | IOVA | Iovance Biotherapeutics, Inc. | 2.70B | -3.86% | 17,406,871 | 324.97M |
| 224 | ATAI | AtaiBeckley Inc. | 2.67B | 0.49% | 2,991,994 | 3.49M |
| 225 | ZLAB | Zai Lab Limited | 2.64B | 12.40% | 1,108,970 | 449.61M |
| 226 | NRIX | Nurix Therapeutics, Inc. | 2.62B | 0.24% | 233,007 | 36.77M |
| 227 | PBH | Prestige Consumer Healthcare Inc. | 2.61B | 1.41% | 153,888 | 1.10B |
| 228 | TRVI | Trevi Therapeutics, Inc. | 2.55B | -2.86% | 553,031 | - |
| 229 | CLOV | Clover Health Investments, Corp. | 2.55B | 3.33% | 3,540,120 | 2.48B |
| 230 | PGEN | Precigen, Inc. | 2.54B | 2.60% | 2,577,420 | 85.72M |
| 231 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.54B | -5.75% | 751,654 | -665.00K |
| 232 | VRDN | Viridian Therapeutics, Inc. | 2.53B | 1.91% | 456,520 | 71.13M |
| 233 | NKTR | Nektar Therapeutics | 2.51B | 1.33% | 272,033 | 55.63M |
| 234 | RARE | Ultragenyx Pharmaceutical Inc. | 2.50B | -1.55% | 1,441,821 | 717.00M |
| 235 | NEOG | Neogen Corporation | 2.47B | 0.35% | 401,134 | 870.40M |
| 236 | HTFL | HeartFlow, Inc. | 2.47B | 5.17% | 172,697 | 191.42M |
| 237 | XRAY | DENTSPLY SIRONA Inc. | 2.45B | -7.18% | 4,412,797 | 3.64B |
| 238 | PHVS | Pharvaris N.V. | 2.44B | 1.22% | 100,767 | - |
| 239 | UFPT | UFP Technologies, Inc. | 2.43B | 0.89% | 70,672 | 631.64M |
| 240 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.42B | 1.83% | 2,166,647 | 940.61M |
| 241 | AXGN | Axogen, Inc. | 2.41B | 1.18% | 119,793 | 251.17M |
| 242 | KLRA | Kailera Therapeutics, Inc. | 2.41B | -1.48% | 64,173 | - |
| 243 | CDNA | CareDx, Inc. | 2.39B | 3.24% | 520,524 | 458.09M |
| 244 | MLYS | Mineralys Therapeutics, Inc. | 2.39B | 0.26% | 94,055 | - |
| 245 | SLS | SELLAS Life Sciences Group, Inc. | 2.36B | 2.56% | 2,728,961 | - |
| 246 | COAG | Hemab Therapeutics Holdings, Inc. | 2.35B | -3.37% | 247,945 | - |
| 247 | ESTA | Establishment Labs Holdings Inc. | 2.33B | -0.03% | 361,373 | 245.82M |
| 248 | VERA | Vera Therapeutics, Inc. | 2.31B | 0.33% | 528,227 | - |
| 249 | URGN | UroGen Pharma Ltd. | 2.31B | 3.42% | 463,059 | 188.73M |
| 250 | VCEL | Vericel Corporation | 2.29B | 0.04% | 88,327 | 306.30M |
| 251 | BHC | Bausch Health Companies Inc. | 2.28B | 3.30% | 1,488,626 | 10.85B |
| 252 | PVLA | Palvella Therapeutics, Inc. | 2.28B | 2.06% | 59,596 | - |
| 253 | BFLY | Butterfly Network, Inc. | 2.27B | 2.65% | 1,802,814 | 112.14M |
| 254 | SION | Sionna Therapeutics, Inc. | 2.27B | 1.21% | 316,433 | - |
| 255 | HRMY | Harmony Biosciences Holdings, Inc. | 2.26B | 0.28% | 305,807 | 959.90M |
| 256 | NUVB | Nuvation Bio Inc. | 2.26B | 6.14% | 2,375,684 | 169.90M |
| 257 | PGNY | Progyny, Inc. | 2.24B | -5.16% | 1,598,256 | 1.31B |
| 258 | WGS | GeneDx Holdings Corp. | 2.24B | 7.92% | 452,233 | 454.43M |
| 259 | ADMA | ADMA Biologics, Inc. | 2.23B | -1.79% | 1,453,753 | 512.28M |
| 260 | BHVN | Biohaven Ltd. | 2.20B | 1.53% | 375,238 | - |
| 261 | ADUS | Addus HomeCare Corporation | 2.19B | 0.76% | 58,567 | 1.48B |
| 262 | RAPP | Rapport Therapeutics, Inc. | 2.18B | -1.77% | 100,887 | 20.00M |
| 263 | HCM | HUTCHMED (China) Limited | 2.16B | 5.41% | 21,682 | 549.12M |
| 264 | MD | Pediatrix Medical Group, Inc. | 2.15B | 2.45% | 203,893 | 1.95B |
| 265 | NEO | NeoGenomics, Inc. | 2.10B | 4.82% | 324,218 | 766.30M |
| 266 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | -2.29% | 600,671 | 311.51M |
| 267 | STOK | Stoke Therapeutics, Inc. | 2.08B | 0.91% | 317,435 | 27.59M |
| 268 | ATRC | AtriCure, Inc. | 2.06B | 2.53% | 188,105 | 569.62M |
| 269 | AVAH | Aveanna Healthcare Holdings Inc. | 2.05B | 1.13% | 362,979 | 2.52B |
| 270 | TSHA | Taysha Gene Therapies, Inc. | 2.04B | 0.79% | 366,792 | 7.47M |
| 271 | GHRS | GH Research PLC | 2.04B | -2.90% | 168,445 | - |
| 272 | MESO | Mesoblast Limited | 2.04B | 0.96% | 37,140 | 65.38M |
| 273 | ZBIO | Zenas BioPharma, Inc. | 2.02B | -0.78% | 76,699 | 10.00M |
| 274 | SGRY | Surgery Partners, Inc. | 2.01B | 3.75% | 419,899 | 3.34B |
| 275 | ALMR | Alamar Biosciences, Inc. | 2.00B | 2.51% | 31,237 | 87.16M |
| 276 | ABCL | AbCellera Biologics Inc. | 1.98B | -0.77% | 2,599,197 | 66.17M |
| 277 | OCUL | Ocular Therapeutix, Inc. | 1.97B | 2.86% | 549,149 | 52.06M |
| 278 | NBTX | Nanobiotix S.A. | 1.96B | 3.31% | 68,305 | 38.27M |
| 279 | AGIO | Agios Pharmaceuticals, Inc. | 1.90B | -0.53% | 420,848 | 98.34M |
| 280 | NVCR | NovoCure Limited | 1.88B | 2.93% | 288,102 | 699.19M |
| 281 | FBRX | Forte Biosciences, Inc. | 1.88B | -0.01% | 287,267 | - |
| 282 | SNDA | Sonida Senior Living, Inc. | 1.87B | -0.68% | 80,639 | 367.34M |
| 283 | BRVE | Braveheart Bio, Inc. | 1.87B | 1.51% | 296,689 | - |
| 284 | DMRA | Damora Therapeutics, Inc. | 1.85B | 0.40% | 68,030 | - |
| 285 | KARD | Kardigan, Inc. | 1.84B | 1.38% | 51,306 | - |
| 286 | LMAT | LeMaitre Vascular, Inc. | 1.83B | -0.87% | 106,001 | 262.43M |
| 287 | CMPS | COMPASS Pathways plc | 1.82B | -0.33% | 2,057,828 | - |
| 288 | GENB | Generate Biomedicines, Inc. | 1.81B | 1.87% | 200,885 | 26.48M |
| 289 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | 1.42% | 370,888 | 252.25M |
| 290 | PRGO | Perrigo Company plc | 1.78B | 2.23% | 572,452 | 4.14B |
| 291 | BCAX | Bicara Therapeutics Inc. | 1.78B | -1.58% | 121,762 | - |
| 292 | SRPT | Sarepta Therapeutics, Inc. | 1.75B | -1.43% | 1,347,258 | 1.97B |
| 293 | SEPN | Septerna, Inc. | 1.73B | -3.07% | 114,714 | 72.26M |
| 294 | INSP | Inspire Medical Systems, Inc. | 1.72B | 1.17% | 159,008 | 898.74M |
| 295 | FTRE | Fortrea Holdings Inc. | 1.72B | 2.20% | 247,836 | 2.68B |
| 296 | RXRX | Recursion Pharmaceuticals, Inc. | 1.72B | 0.79% | 4,287,959 | 54.86M |
| 297 | AAPG | Ascentage Pharma Group International | 1.71B | 8.25% | 1,663 | 82.08M |
| 298 | IMCR | Immunocore Holdings plc | 1.71B | -2.64% | 93,681 | 430.78M |
| 299 | LKFT | Lakefront Biotherapeutics NV | 1.71B | 2.95% | 70,272 | 1.20B |
| 300 | ZYME | Zymeworks Inc. | 1.70B | 2.40% | 197,978 | 37.13M |
| 301 | OBX | Obsidian Therapeutics, Inc. | 1.69B | -3.35% | 1,305 | - |
| 302 | ANAB | AnaptysBio, Inc. | 1.68B | 3.62% | 264,063 | 232.39M |
| 303 | OMCL | Omnicell, Inc. | 1.68B | 2.05% | 110,906 | 1.25B |
| 304 | BLFS | BioLife Solutions, Inc. | 1.67B | 0.77% | 232,227 | 106.69M |
| 305 | TRLV | Trulieve Cannabis Corp. | 1.66B | -4.17% | 617,384 | 1.17B |
| 306 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | -5.63% | 447,933 | 978.38M |
| 307 | ARDT | Ardent Health, Inc. | 1.64B | -0.26% | 74,390 | 6.41B |
| 308 | NTLA | Intellia Therapeutics, Inc. | 1.64B | 4.45% | 2,677,318 | 59.51M |
| 309 | AGL | agilon health, inc. | 1.61B | 10.76% | 279,428 | 5.92B |
| 310 | ASTH | Astrana Health, Inc. | 1.58B | 2.52% | 386,970 | 3.84B |
| 311 | TYRA | Tyra Biosciences, Inc. | 1.57B | -2.19% | 385,846 | - |
| 312 | TRAX | First Tracks Biotherapeutics, Inc. | 1.57B | -0.66% | 200,422 | - |
| 313 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.56B | -3.36% | 2,125,382 | 208.78M |
| 314 | HCSG | Healthcare Services Group, Inc. | 1.54B | 2.04% | 312,071 | 1.86B |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.54B | -2.51% | 194,681 | 20.00M |
| 316 | XNCR | Xencor, Inc. | 1.53B | 2.70% | 605,174 | 104.97M |
| 317 | KMTS | Kestra Medical Technologies, Ltd. | 1.51B | 2.02% | 77,112 | 95.13M |
| 318 | HROW | Harrow, Inc. | 1.51B | 1.33% | 131,149 | 268.68M |
| 319 | MLTX | MoonLake Immunotherapeutics | 1.50B | 0.69% | 467,659 | - |
| 320 | VIR | Vir Biotechnology, Inc. | 1.50B | 1.31% | 653,381 | 303.23M |
| 321 | INVA | Innoviva, Inc. | 1.49B | -2.13% | 410,453 | 440.00M |
| 322 | PSNL | Personalis, Inc. | 1.49B | 7.06% | 1,438,751 | 69.67M |
| 323 | INNV | InnovAge Holding Corp. | 1.48B | -0.46% | 92,144 | 949.17M |
| 324 | ABSI | Absci Corporation | 1.48B | 5.42% | 814,487 | 1.84M |
| 325 | TNDM | Tandem Diabetes Care, Inc. | 1.48B | 15.06% | 2,654,157 | 1.04B |
| 326 | AVLN | Avalyn Pharma Inc. | 1.48B | 2.02% | 46,399 | - |
| 327 | ENOV | Enovis Corporation | 1.48B | -2.55% | 955,910 | 2.30B |
| 328 | SVRA | Savara Inc. | 1.47B | 0.43% | 600,904 | - |
| 329 | CNMD | CONMED Corporation | 1.46B | -2.03% | 88,666 | 1.37B |
| 330 | AVBP | ArriVent BioPharma, Inc. | 1.43B | -1.26% | 55,711 | - |
| 331 | ATEC | Alphatec Holdings, Inc. | 1.42B | -0.11% | 655,340 | 815.05M |
| 332 | XERS | Xeris Biopharma Holdings, Inc. | 1.42B | 5.71% | 870,004 | 335.41M |
| 333 | PAHC | Phibro Animal Health Corporation | 1.40B | -2.63% | 76,845 | 1.50B |
| 334 | AMN | AMN Healthcare Services, Inc. | 1.38B | 15.19% | 648,135 | 3.43B |
| 335 | AZTA | Azenta, Inc. | 1.38B | 2.21% | 184,407 | 613.81M |
| 336 | LBRX | LB Pharmaceuticals Inc | 1.37B | -0.90% | 130,263 | - |
| 337 | OMDA | Omada Health, Inc. | 1.36B | 17.20% | 1,913,678 | 309.76M |
| 338 | ALVO | Alvotech | 1.35B | -0.26% | 99,528 | 562.04M |
| 339 | AKTS | Aktis Oncology, Inc. | 1.35B | 3.97% | 37,699 | 8.28M |
| 340 | GLUE | Monte Rosa Therapeutics, Inc. | 1.34B | 1.15% | 299,362 | 28.73M |
| 341 | PNTG | The Pennant Group, Inc. | 1.34B | -1.75% | 59,467 | 1.10B |
| 342 | ORIC | ORIC Pharmaceuticals, Inc. | 1.34B | - | 255,025 | - |
| 343 | SDGR | Schrödinger, Inc. | 1.34B | 0.31% | 532,161 | 259.04M |
| 344 | IART | Integra LifeSciences Holdings Corporation | 1.33B | -0.15% | 160,226 | 1.65B |
| 345 | AORT | Artivion, Inc. | 1.31B | 1.71% | 486,954 | 471.47M |
| 346 | IMTX | Immatics N.V. | 1.30B | 1.17% | 162,964 | 43.00M |
| 347 | MNKD | MannKind Corporation | 1.30B | 3.98% | 2,262,585 | 393.63M |
| 348 | NVAX | Novavax, Inc. | 1.30B | 2.07% | 2,660,036 | 413.80M |
| 349 | JBIO | Jade Biosciences, Inc. | 1.30B | -1.75% | 175,968 | - |
| 350 | LTGO | Latigo Biotherapeutics, Inc. | 1.30B | 13.58% | 1,611,401 | - |
| 351 | TDOC | Teladoc Health, Inc. | 1.29B | 6.14% | 2,574,089 | 2.49B |
| 352 | SPTX | Seaport Therapeutics, Inc. | 1.26B | 2.30% | 26,399 | - |
| 353 | VOR | Vor Biopharma Inc. | 1.26B | -1.90% | 379,874 | - |
| 354 | FRNM | Freenome, Inc. | 1.26B | 2.11% | 368,907 | 34.24M |
| 355 | ETON | Eton Pharmaceuticals, Inc. | 1.25B | -1.04% | 52,259 | 86.93M |
| 356 | GDRX | GoodRx Holdings, Inc. | 1.25B | -1.08% | 1,066,692 | 785.23M |
| 357 | CERT | Certara, Inc. | 1.24B | - | 693,808 | 421.75M |
| 358 | INBX | Inhibrx Biosciences, Inc. | 1.23B | -2.63% | 52,776 | 1.30M |
| 359 | DRTS | Alpha Tau Medical Ltd. | 1.20B | 2.16% | 145,407 | - |
| 360 | PRCT | PROCEPT BioRobotics Corporation | 1.19B | 3.32% | 591,506 | 337.34M |
| 361 | IRMD | IRADIMED CORPORATION | 1.18B | 1.09% | 52,622 | 86.34M |
| 362 | MGTX | MeiraGTx Holdings plc | 1.18B | -0.63% | 73,453 | 79.76M |
| 363 | USPH | U.S. Physical Therapy, Inc. | 1.17B | 2.77% | 117,229 | 804.27M |
| 364 | STAA | STAAR Surgical Company | 1.17B | 1.77% | 285,731 | 290.38M |
| 365 | BVS | Bioventus Inc. | 1.17B | -0.57% | 425,130 | 581.85M |
| 366 | WVE | Wave Life Sciences Ltd. | 1.17B | -1.50% | 818,808 | 65.37M |
| 367 | CRVS | Corvus Pharmaceuticals, Inc. | 1.15B | -1.30% | 635,730 | - |
| 368 | CRON | Cronos Group Inc. | 1.15B | 2.77% | 1,336,893 | 179.09M |
| 369 | AHG | Akso Health Group | 1.15B | 1.52% | 1,569 | 13.83M |
| 370 | NUTX | Nutex Health Inc. | 1.15B | 9.55% | 163,756 | 846.72M |
| 371 | EYPT | EyePoint, Inc. | 1.14B | 6.39% | 706,243 | 2.79M |
| 372 | ANRO | Alto Neuroscience, Inc. | 1.11B | 0.49% | 105,666 | - |
| 373 | LMRI | Lumexa Imaging Holdings, Inc. | 1.11B | 1.14% | 204,484 | 1.03B |
| 374 | IVA | Inventiva S.A. | 1.10B | 4.94% | 318,643 | 7.94M |
| 375 | CGEM | Cullinan Therapeutics, Inc. | 1.08B | -2.06% | 105,910 | - |
| 376 | OLMA | Olema Pharmaceuticals, Inc. | 1.05B | 1.61% | 195,782 | - |
| 377 | APMD | Apnimed, Inc. | 1.05B | -5.69% | 75,953 | 120.15M |
| 378 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.04B | -0.85% | 1,465,964 | 41.47M |
| 379 | SANA | Sana Biotechnology, Inc. | 1.04B | 1.47% | 705,904 | - |
| 380 | ODTX | Odyssey Therapeutics, Inc. | 1.04B | 0.37% | 29,159 | 99.00K |
| 381 | REPL | Replimune Group, Inc. | 1.03B | -4.70% | 5,608,054 | - |
| 382 | OPK | OPKO Health, Inc. | 1.02B | 3.41% | 817,012 | 587.90M |
| 383 | PCRX | Pacira BioSciences, Inc. | 1.00B | -1.56% | 153,600 | 746.16M |
| 384 | ARDX | Ardelyx, Inc. | 993.06M | -17.45% | 11,281,892 | 450.89M |
| 385 | GMRS | GMR Solutions Inc. | 986.94M | 4.35% | 128,124 | 5.83B |
| 386 | JANX | Janux Therapeutics, Inc. | 980.63M | -0.12% | 185,502 | 24.00M |
| 387 | CSTL | Castle Biosciences, Inc. | 965.98M | 3.77% | 62,911 | 357.28M |
| 388 | GERN | Geron Corporation | 965.49M | -4.14% | 3,997,374 | 204.56M |
| 389 | AVTX | Avalo Therapeutics, Inc. | 957.02M | -3.26% | 260,100 | 59.00K |
| 390 | OMER | Omeros Corporation | 940.88M | -1.14% | 459,578 | 9.89M |
| 391 | AMPH | Amphastar Pharmaceuticals, Inc. | 936.53M | 7.22% | 498,701 | 730.02M |
| 392 | COLL | Collegium Pharmaceutical, Inc. | 933.77M | -1.10% | 396,122 | 808.21M |
| 393 | GLAS | Glass House Brands Inc. | 900.41M | 3.72% | 260,408 | 177.68M |
| 394 | ABUS | Arbutus Biopharma Corporation | 897.81M | 0.11% | 289,665 | 191.45M |
| 395 | ANNX | Annexon, Inc. | 891.30M | -2.86% | 479,624 | - |
| 396 | TBPH | Theravance Biopharma, Inc. | 877.71M | 0.09% | 161,483 | 109.78M |
| 397 | INMD | InMode Ltd. | 875.43M | 0.73% | 169,336 | 374.63M |
| 398 | ATTO | Attovia Therapeutics, Inc. | 873.49M | -0.39% | 120,219 | 1.35M |
| 399 | TALK | Talkspace, Inc. | 871.90M | -0.10% | 5,685,011 | 245.73M |
| 400 | QDEL | QuidelOrtho Corporation | 864.66M | -22.30% | 2,784,568 | 2.67B |
| 401 | DSGN | Design Therapeutics, Inc. | 858.62M | -0.36% | 95,464 | - |
| 402 | AURA | Aura Biosciences, Inc. | 857.58M | 0.71% | 166,747 | - |
| 403 | AVR | Anteris Technologies Global Corp. | 845.91M | 3.83% | 129,579 | 1.85M |
| 404 | KURA | Kura Oncology, Inc. | 840.69M | 2.05% | 225,976 | 71.64M |
| 405 | HSTM | HealthStream, Inc. | 840.49M | 2.31% | 35,600 | 321.12M |
| 406 | SLDB | Solid Biosciences Inc. | 837.81M | -2.30% | 374,843 | - |
| 407 | SIBN | SI-BONE, Inc. | 830.94M | 2.21% | 82,622 | 213.60M |
| 408 | SGP | SpyGlass Pharma, Inc. | 818.45M | -1.09% | 32,013 | - |
| 409 | ACRS | Aclaris Therapeutics, Inc. | 812.14M | -4.52% | 797,466 | 8.22M |
| 410 | MNPR | Monopar Therapeutics Inc. | 802.75M | -0.31% | 136,971 | - |
| 411 | DRUG | Bright Minds Biosciences Inc. | 797.11M | -0.15% | 50,555 | - |
| 412 | DBVT | DBV Technologies S.A. | 795.72M | -2.47% | 400,703 | 5.04M |
| 413 | CLYM | Climb Bio, Inc. | 792.52M | -1.14% | 498,537 | - |
| 414 | TENX | Tenax Therapeutics, Inc. | 785.34M | 3.01% | 1,175,381 | - |
| 415 | AHCO | AdaptHealth Corp. | 777.78M | -3.56% | 2,649,974 | 3.36B |
| 416 | PHR | Phreesia, Inc. | 776.36M | 9.98% | 610,609 | 495.59M |
| 417 | CADL | Candel Therapeutics, Inc. | 773.73M | -0.19% | 352,634 | - |
| 418 | OCS | Oculis Holding AG | 772.97M | 3.39% | 166,819 | 1.45M |
| 419 | PHAR | Pharming Group N.V. | 771.24M | -0.55% | 3,532 | 366.48M |
| 420 | RIGL | Rigel Pharmaceuticals, Inc. | 749.62M | 2.32% | 112,807 | 276.79M |
| 421 | SSII | SS Innovations International, Inc. | 738.49M | -0.54% | 22,979 | 48.47M |
| 422 | CTMX | CytomX Therapeutics, Inc. | 732.57M | -0.15% | 1,058,636 | 18.30M |
| 423 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 721.77M | 2.62% | 45,938 | - |
| 424 | CBIO | Crescent Biopharma, Inc. | 714.24M | 1.57% | 37,622 | 11.88M |
| 425 | GYRE | Gyre Therapeutics, Inc. | 712.97M | -0.08% | 11,576 | 109.82M |
| 426 | IRWD | Ironwood Pharmaceuticals, Inc. | 705.37M | 0.59% | 713,292 | 389.32M |
| 427 | EVO | Evotec SE | 702.97M | 1.72% | 30,913 | 859.03M |
| 428 | NGNE | Neurogene Inc. | 702.92M | -0.91% | 26,360 | 925.00K |
| 429 | HELP | Cybin Inc. | 702.90M | 2.16% | 942,981 | - |
| 430 | CBLL | CeriBell, Inc. | 701.18M | 1.26% | 65,508 | 95.07M |
| 431 | BBNX | Beta Bionics, Inc. | 699.59M | 10.21% | 319,266 | 119.01M |
| 432 | AGMB | AgomAb Therapeutics NV | 689.47M | 3.70% | 319,716 | - |
| 433 | ALLO | Allogene Therapeutics, Inc. | 683.41M | 0.51% | 2,012,756 | 22.00K |
| 434 | ZVRA | Zevra Therapeutics, Inc. | 676.38M | -4.12% | 471,202 | 136.07M |
| 435 | ACHV | Achieve Life Sciences, Inc. | 675.50M | 0.46% | 230,745 | - |
| 436 | IMMX | Immix Biopharma, Inc. | 672.03M | -6.16% | 823,892 | - |
| 437 | PHAT | Phathom Pharmaceuticals, Inc. | 666.42M | - | 520,200 | 239.66M |
| 438 | STLN | Starling Oncology, Inc. | 665.89M | 33.47% | 4,506,869 | 587.24M |
| 439 | TCMD | Tactile Systems Technology, Inc. | 654.24M | 0.50% | 53,021 | 343.52M |
| 440 | ANGO | AngioDynamics, Inc. | 642.10M | 2.81% | 93,183 | 320.17M |
| 441 | RGNX | REGENXBIO Inc. | 639.24M | -8.16% | 631,824 | 174.48M |
| 442 | BWAY | BrainsWay Ltd. | 638.93M | -1.21% | 31,698 | 56.22M |
| 443 | FTH | Faeth Therapeutics, Inc. | 631.32M | 0.04% | 125,870 | - |
| 444 | TLRY | Tilray Brands, Inc. | 619.08M | 2.82% | 1,823,396 | 915.45M |
| 445 | MDXG | MiMedx Group, Inc. | 612.19M | 0.48% | 353,395 | 355.17M |
| 446 | NVCT | Nuvectis Pharma, Inc. | 610.90M | -0.42% | 82,102 | - |
| 447 | SPRY | ARS Pharmaceuticals, Inc. | 601.78M | 9.19% | 1,161,839 | 98.99M |
| 448 | KIDS | OrthoPediatrics Corp. | 595.30M | -0.13% | 47,520 | 252.72M |
| 449 | SOPH | SOPHiA GENETICS SA | 593.34M | 4.19% | 148,899 | 86.17M |
| 450 | ALT | Altimmune, Inc. | 593.15M | 1.33% | 1,728,089 | 36.00K |
| 451 | CRMD | CorMedix Inc. | 587.56M | -0.27% | 322,942 | 400.05M |
| 452 | TECX | Tectonic Therapeutic, Inc. | 580.79M | 1.85% | 34,669 | - |
| 453 | ARVN | Arvinas, Inc. | 570.82M | 0.58% | 635,050 | 316.70M |
| 454 | ANL | Adlai Nortye Ltd. | 570.40M | 3.03% | 61,760 | 5.00M |
| 455 | VSTM | Verastem, Inc. | 570.30M | 9.81% | 2,592,004 | 87.53M |
| 456 | CTNM | Contineum Therapeutics, Inc. | 564.69M | -2.21% | 125,832 | - |
| 457 | STTK | Shattuck Labs, Inc. | 559.00M | 1.82% | 481,540 | 1.00M |
| 458 | ZURA | Zura Bio Limited | 558.59M | 2.98% | 418,951 | - |
| 459 | MPLT | MapLight Therapeutics, Inc. | 557.75M | -7.38% | 129,529 | - |
| 460 | SLN | Silence Therapeutics plc | 557.36M | 0.68% | 197,586 | 839.00K |
| 461 | FDMT | 4D Molecular Therapeutics, Inc. | 554.65M | 0.57% | 98,543 | 88.24M |
| 462 | AUTL | Autolus Therapeutics plc | 550.92M | 3.50% | 1,095,519 | 92.62M |
| 463 | PRME | Prime Medicine, Inc. | 547.27M | 2.71% | 953,812 | 4.07M |
| 464 | ARTV | Artiva Biotherapeutics, Inc. | 545.65M | -3.02% | 127,615 | 251.00K |
| 465 | CTEV | Claritev Corporation | 541.44M | 18.33% | 176,388 | 994.67M |
| 466 | CTKB | Cytek Biosciences, Inc. | 540.73M | - | 171,277 | 206.71M |
| 467 | SGMT | Sagimet Biosciences Inc. | 529.83M | -1.83% | 261,513 | - |
| 468 | DCTH | Delcath Systems, Inc. | 529.04M | -0.94% | 605,135 | 95.42M |
| 469 | RLMD | Relmada Therapeutics, Inc. | 527.07M | -6.42% | 1,105,591 | - |
| 470 | VREX | Varex Imaging Corporation | 523.46M | 1.39% | 56,566 | 857.50M |
| 471 | FLGT | Fulgent Genetics, Inc. | 522.24M | 2.32% | 86,794 | 323.93M |
| 472 | EIKN | Eikon Therapeutics, Inc. | 520.27M | 4.34% | 450,063 | - |
| 473 | BIOA | BioAge Labs, Inc. | 518.76M | 3.55% | 329,043 | 10.36M |
| 474 | SRTA | Strata Critical Medical, Inc. | 517.53M | 4.65% | 669,467 | 255.98M |
| 475 | DNA | Ginkgo Bioworks Holdings, Inc. | 510.18M | -8.12% | 827,516 | 132.42M |
| 476 | ASMB | Assembly Biosciences, Inc. | 508.80M | -0.08% | 43,555 | 71.10M |
| 477 | EVMN | Evommune, Inc. | 504.44M | 4.67% | 108,827 | 10.00M |
| 478 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 479 | PROK | ProKidney Corp. | 495.38M | - | 349,530 | 889.00K |
| 480 | NPCE | NeuroPace, Inc. | 491.63M | 3.74% | 76,383 | 99.53M |
| 481 | OVID | Ovid Therapeutics Inc. | 489.93M | -0.94% | 348,957 | 7.12M |
| 482 | BLSM | BlossomHill Therapeutics, Inc. | 489.38M | -0.19% | 719,357 | - |
| 483 | AQST | Aquestive Therapeutics, Inc. | 488.69M | -0.64% | 761,519 | 50.27M |
| 484 | VALN | Valneva SE | 485.37M | 0.93% | 25,977 | 180.25M |
| 485 | EOLS | Evolus, Inc. | 481.51M | -1.62% | 374,479 | 316.49M |
| 486 | RZLT | Rezolute, Inc. | 480.55M | -2.13% | 250,574 | - |
| 487 | KYTX | Kyverna Therapeutics, Inc. | 477.85M | 1.42% | 167,734 | - |
| 488 | CERS | Cerus Corporation | 477.61M | 2.16% | 917,225 | 221.55M |
| 489 | SCTX | Scribe Therapeutics Inc. | 475.95M | -0.71% | 44,082 | 36.28M |
| 490 | IKT | Inhibikase Therapeutics, Inc. | 475.85M | 1.04% | 194,277 | 1.00 |
| 491 | QTTB | Q32 Bio Inc. | 471.76M | -2.16% | 281,934 | 53.74M |
| 492 | PRLD | Prelude Therapeutics Incorporated | 464.15M | - | 43,029 | 16.72M |
| 493 | BNTC | Benitec Biopharma Inc. | 459.32M | 1.83% | 10,397 | - |
| 494 | EVH | Evolent Health, Inc. | 457.50M | 13.09% | 2,243,669 | 2.10B |
| 495 | PRTA | Prothena Corporation plc | 453.38M | 0.93% | 178,607 | 54.53M |
| 496 | CABA | Cabaletta Bio, Inc. | 451.66M | 0.36% | 1,385,143 | - |
| 497 | EDIT | Editas Medicine, Inc. | 446.57M | 0.34% | 968,004 | 47.01M |
| 498 | NRC | NRC Health | 443.28M | 2.93% | 37,210 | 140.00M |
| 499 | VTVT | vTv Therapeutics Inc. | 441.28M | 2.74% | 74,246 | 36.84M |
| 500 | SLBT | SL Science Holding Limited | 438.00M | -0.73% | 16,554 | 3.27M |